Increased MDA content and impaired SOD activity were observed in AD, and these markers are sensitive indexes for the monitoring of cognitive alterations in AD progression (Pan et al., 2012; Wang et al., 2013; Xu et al., 2014). Here, SOD1 is linked to Alzheimer disease.